Top 50 Medical Device VC Funds & Investors in Middle East (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Diffusion Capital Partners
VC Fund
|
10 | Turkey, United States, United Kingdom | Seed, Series A | Software, Information Technology, Analytics | $439k–$2.7M |
|
Israel Innovation Authority
VC Fund
|
9 | Israel, United States, Mali | Grant, Seed, Pre-Seed | Health Care, Artificial Intelligence, Biotechnology | $140k–$5M |
|
Pontifax
VC Fund
|
8 | United States, Israel, France | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $6.3M–$128M |
|
Trendlines Group
VC Fund
|
7 | Israel, Singapore, United Kingdom | Seed, Series A | Health Care, Biotechnology, Medical Device | $650k–$15M |
|
Accelmed
VC Fund
|
5 | Israel, United States | Series D, Series A | Health Care, Medical Device, Medical | $695k–$96M |
|
OurCrowd
VC Fund
|
5 | Israel, United States, New Zealand | Series B, Series A, Seed | Software, Artificial Intelligence, Health Care | $604k–$65M |
|
Elron Ventures
VC Fund
|
4 | Israel, United States, China | Seed, Series A | Information Technology, Software, Cyber Security | $1M–$17M |
|
Btomorrow Ventures
VC Fund
|
4 | United States, United Kingdom, India | Series A, Seed, Series B | Health Care, Wellness, Food and Beverage | |
|
J-Ventures
VC Fund
|
4 | United States, Israel | Series A, Seed, Pre-Seed | Software, Health Care, Machine Learning | $3M–$27M |
|
Longevity Venture Partners
VC Fund
|
4 | Israel, United States, United Kingdom | Seed, Pre-Seed, Series A | Health Care, Medical Device, Artificial Intelligence | $1.2M–$11M |
|
Maccabi Fund
VC Fund
|
4 | Israel, United States | Seed, Series A, Grant | Health Care, Medical Device, Artificial Intelligence | $1.5M–$15M |
|
Agriline
VC Fund
|
4 | Israel | Seed, Series A | Health Care, Medical Device, Medical | $1.3M–$17M |
|
OrbiMed
VC Fund
|
3 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $10M–$151M |
|
Robin Hood Ventures
VC Fund
|
3 | United States, Israel | Seed, Series A | Software, Health Care, Biotechnology | $100k–$11M |
|
ALIVE Israel HealthTech Fund
VC Fund
|
3 | Israel, United States | Series A, Series C, Series B | Health Care, Medical, Medical Device | $4.4M–$55M |
|
TT Ventures
VC Fund
|
3 | Turkey, United States, United Kingdom | Seed, Pre-Seed | Software, Information Technology, Artificial Intelligence | $1k–$2M |
|
Consensus Business Group
VC Fund
|
3 | Israel, United States, United Kingdom | Seed, Series A | Health Care, Medical Device, Medical | $1M–$10M |
|
Eczacıbaşı Momentum
VC Fund
|
3 | Turkey, United States, Morocco | Seed, Series A, Pre-Seed | FinTech, Health Care, Biotechnology | $125k–$12M |
|
Rimonci Capital
VC Fund
|
3 | Israel, France, United States | Series A, Seed, Series B | Health Care, Medical Device, Eyewear | $3.6M–$11M |
|
Magma Venture Partners
VC Fund
|
3 | Israel, United States, Mexico | Series A, Series B, Seed | Software, Mobile, Enterprise Software | $800k–$25M |
|
OTV
VC Fund
|
3 | United States, Israel, Ghana | Series A, Series B, Seed | Health Care, Medical, Medical Device | $5M–$50M |
|
Iron Nation
VC Fund
|
3 | Israel, United States, Germany | Seed, Series A, Series B | Health Care, Artificial Intelligence, Software | $850k–$20M |
|
Triventures
VC Fund
|
3 | United States, Israel, Ireland | Series A, Series B | Health Care, Medical Device, Medical | $6M–$28M |
|
Docor International Management
VC Fund
|
3 | Israel, United States | Series C, Series A | Health Care, Biotechnology, 3D Technology | $13M–$22M |
|
Merz Therapeutics
VC Fund
|
2 | Israel | Corporate Round, Venture - Series Unknown | Health Care, Therapeutics, Medical Device | |
|
Indaco Venture Partners
VC Fund
|
2 | Italy, United States, United Kingdom | Series A, Series B | Biotechnology, Health Care, Medical | |
|
Turkey Development Fund
VC Fund
|
2 | Turkey, United Kingdom | Series A, Seed, Series B | Information Technology, Software, SaaS | |
|
Boston Scientific
VC Fund
|
2 | United States, Israel, Canada | Series B, Series C, Series D | Health Care, Medical Device, Biotechnology | |
|
The Chartered Group
VC Fund
|
2 | Israel | Series A, Private Equity | Biopharma, Agriculture, Health Care | |
|
Kli Capital
VC Fund
|
2 | United States, Israel, Mexico | Seed, Series A | Health Care, Software, Wellness | |
|
Medtronic
VC Fund
|
2 | United States, Israel, China | Series C, Series B | Health Care, Medical Device, Medical | |
|
Italian Angels for Growth
VC Fund
|
2 | Italy, United States, United Kingdom | Seed, Angel, Series A | Software, E-Commerce, Health Care | $219k–$14M |
|
Smith & Nephew
VC Fund
|
2 | United States, Israel, United Kingdom | Series B, Series C | Medical Device, Medical, Health Care | $2.7M–$30M |
|
Connecticut Innovations
VC Fund
|
2 | United States, Israel, Canada | Seed, Series A | Health Care, Biotechnology, Software | $300k–$25M |
|
Arkin Holdings
VC Fund
|
2 | Israel, United States, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Medical | $2M–$95M |
|
Tarvenn Ventures
VC Fund
|
2 | Turkey, United States | Seed, Pre-Seed, Series A | Software, E-Commerce, SaaS | $50k–$600k |
|
Terra Venture Partners
VC Fund
|
2 | Israel, United States | Seed, Series A, Series B | Software, Machine Learning, Artificial Intelligence | $1M–$30M |
|
Keiretsu Forum Northwest
VC Fund
|
2 | United States, Spain, Canada | Series A, Seed | Health Care, Software, Biotechnology | $507k–$8M |
|
Emerge Ventures
VC Fund
|
2 | Israel, United States | Series A, Seed, Series B | Software, Information Technology, Artificial Intelligence | $2.5M–$80M |
|
ZORA Ventures
VC Fund
|
2 | Israel, United States, United Kingdom | Seed, Series A, Convertible Note | Biotechnology, Health Care, Internet | $1M–$8.1M |
|
Sanara Ventures
VC Fund
|
2 | Israel | Seed, Series A | Health Care, Medical, Medical Device | $800k–$6M |
|
Sofinnova Partners
VC Fund
|
2 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $6.6M–$109M |
|
Mithril Capital Management
VC Fund
|
2 | United States, United Kingdom, Israel | Series C, Series B, Series D | Software, Health Care, Information Technology | $10M–$300M |
|
Joyance Partners
VC Fund
|
2 | United States, Germany, United Kingdom | Seed, Series A, Pre-Seed | Health Care, Biotechnology, Wellness | $425k–$13M |
|
HealthpointCapital
VC Fund
|
2 | Israel, United States | Series B, Series C | Medical, Biotechnology, Manufacturing | $5M–$15M |
|
aMoon Fund
VC Fund
|
2 | United States, Israel, France | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $5.7M–$93M |
|
Israel Biotech Fund
VC Fund
|
2 | Israel, United States | Series B, Series C, Series A | Biotechnology, Health Care, Pharmaceutical | $9M–$45M |
|
TechWald Holding S.p.A.
VC Fund
|
2 | Israel, Switzerland, United States | Series A, Series B, Series C | Health Care, Medical, Medical Device | $3.6M–$60M |
|
Chartered Opus
VC Fund
|
2 | Israel | Series A | Wellness, Biotechnology, Manufacturing | $3M–$3.5M |
|
Johnson & Johnson Robotics and Digital Solutions
VC Fund
|
2 | United States, Israel, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $300k–$100M |
| Access all 50 VC funds in Middle East Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Diffusion Capital Partners (DCP) is Turkey's leading Venture Capital fund manager with a focus on deep-tech opportunities.
Show more...Investment focus
- Industry: Software, Information Technology, Analytics
- Stage:Seed, Series A
- Geography: Turkey, United States, United Kingdom
Investor stats
- Total investments: 58
- Round size: Seed $439k–$2.7M; Series A $985k–$2.5M
- Lead/follow: 57% lead, 43% follow
- Last fund: May invest from a new fund soon — raised $32M in 2020
Portfolio highlights
- V-Count — V-Count works with 550+ brands, 25.000+ locations in 105+ countries.
- Webee — Discover WeBee's high-tech hospitality solutions, ensure a contactless guest experience, improve TripAdvisor scores and maximize revenue.
- Mikro Biyosistemler Inc. — Mikro Biyosistemler is a biomedical microsystems company focuses on development of microfluidics and lab-on-a-chip systems for biomedical applications.
The Israel Innovation Agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Biotechnology
- Stage:Grant, Seed, Pre-Seed
- Geography: Israel, United States, Mali
Investor stats
- Total investments: 185
- Round size: Seed $500k–$5M; Grant $140k–$3.5M; Pre-Seed $150k–$2.1M
- Lead/follow: 49% lead, 51% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Brevel — Brevel developed a disruptive cultivation technology for sustainable, low cost and high quality production of microalgae for various yet untapped markets. The technology is based on high-tech indoor, sterile and fully automated systems which are illuminated from within at high intensity. The technology enables the surprising results of more than90% cost reduction and up to 200 higher yields compared to current alternatives. Brevel is using the advantageous production capabilities to enter multiple markets where microalgae derived products are needed.
- NanoGhosts — NanoGhosts’ technology is based on its founder’s research, that the Technion's commercial unit has patented in the U.S. and Europe.
- GeoRank Studio — GeoRank Studio is a specialist SEO, Generative Engine Optimisation (GEO), and Reputation Management agency helping businesses across the UK, EU, and US gain visibility in both traditional and AI-powered search.As AI search engines including ChatGPT, Perplexity, and Google AI Overviews now answer a growing share of commercial queries without aclick, GeoRank Studio helps businesses adapt. We implement the technical and content changes needed to get brands cited in AI-generated answers — a discipline known as Generative Engine Optimisation or GEO.Our core services include technical SEO audits and full implementation, GEO optimisation including FAQPage schema markup, entity optimisation, and AI crawler configuration, reputation management including review removal from Google and Trustpilot, negative SERP suppression, and monthly AI citation tracking reports.GeoRank Studio was founded in 2022 and operates fully remotely, serving clients in professional services, SaaS, hospitality, luxury retail, and e-commerce. All packages include a 14-day money-back guarantee.Official Website: georankstudio.com
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 113
- Round size: Series A $6.3M–$110M; Series B $20M–$128M; Series C $12M–$101M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $14M in 2020
Portfolio highlights
- ArQule — ArQule, Inc. is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics. The Company employs technologies, such as its ArQule Kinase Inhibitor Platform (AKIP) to design and develop drugs. The Company's product is ARQ 197, an orally administered inhibitor of the c-Met receptor tyrosine kinase. ARQ197 is being evaluated as monotherapy and in combination therapy in a Phase II clinical development program that includes trials in Microphthalmia Transcription Factor (MiT) associated tumors, non-small cell lung cancer (NSCLC), pancreatic adenocarcinoma and hepatocellular carcinoma (HCC). The Company has licensed commercial rights to ARQ 197 for human cancer indications to Daiichi Sankyo Co., Ltd. (Daiichi Sankyo) in the United States, Europe, South America and the rest of the world, excluding Japan and certain other Asian countries, where it has licensed commercial rights to Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin).
- Graviton Bioscience — Curing Disease through Restored Homeostasis
- Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Series A
- Geography: Israel, Singapore, United Kingdom
Investor stats
- Total investments: 69
- Round size: Seed $650k–$4.1M; Series A $2.3M–$15M
- Lead/follow: 20% lead, 80% follow
- Last fund: May invest from a new fund soon — raised $40M in 2019
Portfolio highlights
- IBI-Ag — IBI-Ag is a biotechnology company developing a new class of bioinsecticides. IBI-Ag is focused on the discovery and development of new types of biological solutions that utilize environmentally friendly technology to control insects. IBI-Ag utilizes breakthrough technology to produce efficient, selective, and safe bio-insect control solutions.IBI-Ag technology is highly cost-effective due to its fermentation suitability enabling farmers to produce agricultural produce at a low cost.
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.
Accelmed is a venture capital firm that funds private and public medical device companies with significant market potential and proven clinical data.Concentrating on medical device companies that have already reached the revenue stage enables the firm to assist companies in benefiting from its managerial capabilities and financial resources.Together with the management teams of their portfolio companies, the Accelmed can steer the way from the clinical-stage to a profitable business with a clear commercial plan, thereby accelerating the path to a successful exit.In 2009, Mori Arkin and Uri Geiger, the co-founders of Accelmed, established the firm in Herzliya, Tel Aviv.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series D, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 37
- Round size: Series A $695k–$24M; Series D $13M–$96M
- Lead/follow: 46% lead, 54% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Corvia Medical — Corvia Medical is a medical device company, focuses on developing structural heart devices for the treatment of heart failure. The company develops InterAtrial Shunt Device (IASD), a transcatheter device designed to treat diastolic heart failure (DHF), also known as heart failure with preserved ejection fraction (HFpEF). It was founded in 2009and headquartered in Andover, Massachusetts.
- UltraClear —
- GT Medical Technologies — GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The company's first product, GammaTile™ is protected by 10 US and 2Canadian issued patents, and 1 EPO patent. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 120 patients with recurrent brain tumors in a clinical trial at Barrow Neurological Institute (BNI) and observed significant clinical improvement.
Invest in exclusive and pre-vetted startups, late-stage companies, and top tier funds - private market access made simple, transparent, and institutional-grade.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series B, Series A, Seed
- Geography: Israel, United States, New Zealand
Investor stats
- Total investments: 286
- Round size: Seed $604k–$10M; Series A $5.3M–$22M; Series B $7M–$65M
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Oriient — Bringing the GPS revolution indoors with the most scalable and accessible solution for buildings. No Hardware, Cost Effective, and Highly Accurate.
- Sequentify — Sequentify provides a technology that is based on tools from the synthetic biology and AI software worlds for targeted DNA sequencing applications such as cancer diagnostics, carrier screening, COVID-19 surveillance and other applications.
- BetterSeeds — The company focuses on non-GMO genome editing using CRISPR-Cas9 for creating a novel breed of seeds and crop traits that address the 21st-century agriculture challenges. BetterSeeds provides advanced seeds enabling better crops for mechanized harvesting, extreme e climate resistance, higher calory and nutrient values, and more.
Elron Ventures is an early-stage investor committed to turning promising ideas into global industry leaders, with a proven track record of investments and successful M&As worldwide. Elron invests in cyber security and B2B software. Since its establishment in 1962, Elron stands on the forefront of Israeli innovation both as a founder and earlyinvestor in companies across various industries such as Elbit, Medingo, Given Imaging, Cloudyn, Cyber Secdo, and Alcide.
Show more...Investment focus
- Industry: Information Technology, Software, Cyber Security
- Stage:Seed, Series A
- Geography: Israel, United States, China
Investor stats
- Total investments: 65
- Round size: Seed $1.5M–$15M; Series A $1M–$17M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- Cybersixgill — Cybersixgill is the leader in cyber threat intelligence enablement and enrichment. Their fully automated threat intelligence solutions help organizations fight cyber crime, detect phishing, data leaks, fraud and vulnerabilities as well as amplify incident response – in real-time. The Cybersixgill Investigative Portal empowers security teams withcontextual and actionable insights as well as the ability to conduct real-time investigations. Rich data feeds such as Darkfeed™ and DVE Score™ harness Cybersixgill’s unmatched intelligence collection capabilities and deliver real-time intel into organizations' existing security systems. Most recently, Cybersixgill introduced agility to threat intel with their CI/CP methodology (Continuous Investigation/Continuous Protection). Current customers include enterprises, financial services, MSSPs, governments and law enforcement entities.
- CartiHeal — Target improved outcomes in the treatment of knee cartilage and osteochondral defects with a porous, biocompatible and biodegradable off-the-shelf implant.
- Brainsgate — Established in 2000, BrainsGate is a medical device company committed to developing innovative therapies for patients suffering from Central Nervous System (CNS) diseases.BrainsGate's platform...
Btomorrow Ventures (BTV) is the corporate venturing unit of BAT. BAT is building A Better Tomorrow by reducing the health impact of its business by transforming into a truly consumer-centric multi-category CPG company. We are dedicated to partnering with ambitious and passionate entrepreneurs to realise their vision by providing a platform toenhance innovation and accelerate growth.
Show more...Investment focus
- Industry: Health Care, Wellness, Food and Beverage
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, India
Investor stats
- Total investments: 44
- Lead/follow: no public data
Portfolio highlights
- Tru — Obsessively formulated by fusing flavor with function, each of our tasty innovations perform when you need it most. From the time you wake up until the second your head hits the pillow, we elevate every moment one sip at a time.
- Awake Chocolate — AWAKE Chocolate combines delicious milk chocolate.
- PHILTER Labs — Philter Labs presents an innovative smoke filter for E-Cig, Vape Pen, & CBD Pen. Filters smoke from entering shared space while you still enjoy the experience.
J- Ventures is a Silicon Valley based group of VC funds with over $60m under management. Backed by 400+ leading Investors ( 140+ Serial founders, 100+ VCs, 170+ Fortune 500 Executives) as LPs. Our active-LP venture fund brings the power of this connected & intellectual capital to add real value to the companies we invest in and create aremarkable difference by helping our founders grow and scale to markets quicker. Based in Silicon Valley with investors from 15 communities - Tel Aviv, NYC, LA, London, Miami, Boston, and more. Since 2016 the group made over 50 investments, 4 unicorns and over 10 exits.
Show more...Investment focus
- Industry: Software, Health Care, Machine Learning
- Stage:Series A, Seed, Pre-Seed
- Geography: United States, Israel
Investor stats
- Total investments: 74
- Round size: Seed $3M–$7.2M; Series A $7.7M–$27M
- Lead/follow: 3% lead, 97% follow
- Last fund: Likely still investing — raised $32M in 2023
Portfolio highlights
- Zenskar — Zenskar seamlessly manages complex subscription and usage based billing. Meter high throughput data, and automate revenue accounting, analytics & dunning.
- CopilotKit — CopilotKit is the full-stack framework for building user interactive agents and copilots. The company behind the AG-UI Protocol.
- RAAAM Memory Technologies Ltd. — RAAAM provides a unique on-chip memory technology that offers the highest-density embedded memory solution in any standard CMOS process.RAAAM develops a high-density memory technology that allows for up to 50% higher on-chip memory density with no cost, complexity, or performance-penalty.
Longevity Venture Partners is an early-stage venture capital firm committed to assisting entrepreneurs in the Silvertech, Healthcare, and Wellness sectors.
Show more...Investment focus
- Industry: Health Care, Medical Device, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 13
- Round size: Seed $4M–$11M; Pre-Seed $1.2M–$3.6M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- CustoMED — CustoMed transforms surgical planning and execution. It does this by converting medical imaging into 3D visualizations, planning procedures, and producing customized 3D-printed surgical solutions at scale in a matter of minutes, all while streamlining the process and providing surgical excellence.
- Sensifai Health — Powered by insights from wearables, Sensifai alerts inflammatory flares before symptoms enabling true early intervention.
- Urologic Health — Urologic Health developing innovative solutions to improve bladder function diagnosis, monitoring, and treatment of urinary disorders.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Maccabi Fund is an investment fund.
Show more...Investment focus
- Industry: Health Care, Medical Device, Artificial Intelligence
- Stage:Seed, Series A, Grant
- Geography: Israel, United States
Investor stats
- Total investments: 8
- Round size: Seed $1.5M–$3.5M; Series A $1.5M–$15M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- AccuLine — AccuLine is a digital healthcare company, which was founded with the vision to saves the lives of millions of people worldwide. AccuLine is developing CORA—a smart, accurate, and easy to use exam for the early detection of coronary artery disease. The clinically validated CORA evaluates a patient's risk of having coronary artery diseasethrough advanced analysis and detection of two newly discovered biomarkers in the heart’s electrical activity. CORA’s early detection will assist in the prevention of sudden cardiac deaths, while lowering costs of cardiovascular related illness.
- Olive Diagnostics — It's About me (IAM) has developed a passive sensor mounted to the rim of the toilet that performs urinalysis every time the end-user urinates. The information is uploaded to a robust data science platform to track existing and progressing conditions. Real-time, actionable notifications will be sent to the end user for proactive medical ornutritional care. Ongoing biomarker tracking for hydration, Alcohol, Pregnancy, Ovulation, Keytones, etc. is used to develop a comprehensive personal user profile.The technology will also be used for pharma and CRO companies to track the usage of drugs. While drug compliance issues plague health care systems around the world, I AM's technology will provide a reliable and continuous solution for tracking when and how people take their medicine or clinical trial drug.Nonindustrial nations will now have home access to urine lab services.
- Rhino Federated Computing —
Agriline is the investment vehicle owned by a trust of which Trendlines' controlling shareholder Vincent Tchenguiz.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Series A
- Geography: Israel
Investor stats
- Total investments: 15
- Round size: Seed $1.3M–$7.5M; Series A $5M–$17M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
- SetBone Medical — SetBone Medical develops a new bone cement for the treatment of VCF and primarily caused by osteoporosis.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 615
- Round size: Series A $10M–$140M; Series B $24M–$151M; Series C $15M–$131M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Avedro — Avedro is a privately held medical device and pharmaceutical company advancing the science and technology of corneal cross-linking. Avedro recently completed its US‐based, multi-centered, Phase III studies of corneal cross-linking for the treatment of progressive keratoconus and corneal ectasia following refractive surgery. Outside the UnitedStates, Avedro has commercialized both VibeX and its KXL System for performing Lasik Xtra and accelerated cross-linking. Additionally, Avedro is developing the science of Thermo‐biomechanics for therapeutic medical applications. The Keraflex® refractive correction procedure is the first technology developed from the Thermo‐biomechanics platform and is a non‐invasive, incision‐less ophthalmic procedure for flattening the cornea without the removal of tissue. Keraflex offers the unique ability to induce refractive change without weakening the cornea’s biomechanical integrity, as happens with Lasik and other refractive correction procedures. Keraflex is commercially available outside of the United States.
- Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with advanced immunological diseases.
- EDDA Technology — EDDA Technology offers computer assistance to the patient care management cycle and enables early detection and diagnosis of diseases.
Robin Hood Ventures investments for startups range from $250,000 to $1 million. We syndicate with venture capitalists, institutions, and other network angels.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United States, Israel
Investor stats
- Total investments: 149
- Round size: Seed $210k–$4.3M; Series A $100k–$11M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Epoxy.ai — We make sports viewing and gaming easy and fun for everyone
- Lia — LIA Diagnostics is redesigning pregnancy tests to addresses the challenges surrounding privacy, usability and sustainability in current pregnancy tests.
- Beckon Ice cream — Beckon is calling people back to REAL ice cream that is unbelievably delicious and surprisingly lactose-free. Founded on the belief that n...
ALIVE Israel HealthTech Fund is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series C, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 15
- Round size: Series A $4.4M–$17M; Series B $22M–$30M; Series C $30M–$55M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Navina — Navina uses medically-informed AI to replace disorganized patient data with an intuitive Patient Portrait - a logical grid that makes it possible for every primary care physician to assess even the most complex cases in minutes. Designed for and loved by physicians, Navina allows for high quality and empathic patient care, resulting in better treatment, reduced missed diagnoses and enhanced financial performance for providers and payers.
- Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
- Magenta Medical — Founded in October, 2012, Magenta Medical Ltd. is a privately held company that is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.
TT Ventures is the corporate venture capital arm of Turk Telekom.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: Turkey, United States, United Kingdom
Investor stats
- Total investments: 68
- Round size: Seed $50k–$2M; Pre-Seed $1k–$400k
- Lead/follow: 7% lead, 93% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- VenueX — VenueX enables retailers to showcase their products, POI and indoor maps to shoppers searching online!
- OctoXLabs — OctoXLabs is dedicated to tackling the most pressing challenges in the fields of Information Technology and Cybersecurity, delivering innovative solutions that enhance system resilience, data protection, and operational efficiency for organizations navigating an increasingly complex digital landscape.
- Mindsite — Mindsite provides e-commerce analytics. Easily monitor key metrics from price to visibility in real time. Increase your online sales.
Acting as advisor to companies within the Tchenguiz Family Trust, Consensus Business Group has amassed a portfolio of over 300,000 residential freeholds worth over £4 billion and a commercial portfolio worth over £2 billion.Consensus Business Group has vast experience and a proven track record of acquiring stock directly from nationalhousebuilders and developers over 20 years.As a result of their strategic investment, Consensus Business Group is believed to be the largest owner and asset manager of residential freehold interests in the UK, representing in excess of 1% of the housing stock in England and 1.2% in Greater London.Their decisions are not subject to procrastinated board approval or credit committees and as a result they are able to perform quickly and consistently. They are not dependent on debt finance and they have immediate cash availability.Consensus Business Group prides itself on having the market knowledge and expertise to stand out from its competitors, and it is their diligent and efficient acquisition practices that ensure swift transactions.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Series A
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 22
- Round size: Seed $1.7M–$4.5M; Series A $1M–$10M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- IBI-Ag — IBI-Ag is a biotechnology company developing a new class of bioinsecticides. IBI-Ag is focused on the discovery and development of new types of biological solutions that utilize environmentally friendly technology to control insects. IBI-Ag utilizes breakthrough technology to produce efficient, selective, and safe bio-insect control solutions.IBI-Ag technology is highly cost-effective due to its fermentation suitability enabling farmers to produce agricultural produce at a low cost.
- MEDX Xelerator — MEDX Xelerator is a unique medical device and digital health incubator. It was founded by MEDX Ventures Group, together with three partners: Boston Scientific, Intellectual Ventures’ Invention Science Fund and Sheba Medical Center. Each of MEDX Xelerator’s partners contributes outstanding core competencies, which complement one another and togethercreate a solid foundation for your success. Our incubator is seeking medical innovations for minimally invasive procedures, medical robotics, medical implants and digital health.Our vision is to leverage the power of MEDX Xelerator, and together with the extraordinary Israeli med tech innovation scene create a local cluster of entrepreneurial companies with breakthrough solutions to true unmet medical needs. Our mission is to nurture those promising technologies into successful medical ventures for the benefit of patients and health care professionals. We see you, the entrepreneur, as the key to success and we are here for you to make it happen.
- Synchrony Medical — Synchrony Medical is a clinical stage medical device company developing LibAirty, a next generation, home-use, airway clearance system designed to help patients with chronic lung disease such as COPD and CF maintain clear lungs with a short, daily, proficient treatment.
Eczacıbaşı Momentum invested in three venture companies and a venture capital fund; Their goal is to invest US$30 million over the next five years as they continue to partner with funds and startups that shape the new normal of modern life, focusing on well-being, consumption, and home-living.
Show more...Investment focus
- Industry: FinTech, Health Care, Biotechnology
- Stage:Seed, Series A, Pre-Seed
- Geography: Turkey, United States, Morocco
Investor stats
- Total investments: 12
- Round size: Seed $125k–$2.6M; Series A $2.5M–$12M
- Lead/follow: 50% lead, 50% follow
- Last fund: May invest from a new fund soon — raised $30M in 2020
Portfolio highlights
- Chari — Chari is an e-commerce and fintech app for traditional retailers in French-Speaking Africa allowing them to order any consumer goods they sell and get delivered for free in less than 24 hours. Chari is also a financial services provider for these retailers, offering them microloans
- Ecomercek — Ninico is a modern and flexible Minimal eCommerce Laravel script. This script is suited for electronic, organic and grocery store, furniture store, clothing store, hitech store and accessories store...
- BillionToOne — We are a team at the forefront of disease detection focused on moving Prenatal Screening and Liquid Biopsy forward.
A dedicated to China-Israel cross border investment.
Show more...Investment focus
- Industry: Health Care, Medical Device, Eyewear
- Stage:Series A, Seed, Series B
- Geography: Israel, France, United States
Investor stats
- Total investments: 10
- Round size: Seed $3.6M–$3.6M; Series A $6.6M–$11M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- EyeYon — EyeYon Medical is an Israeli start-up company that develops innovative medical devices for the treatment of corneal edema.EyeYon Medical was founded by Dr. Daphna Ofer, a senior ophthalmologist, Dr. Arie Marcovich, a senior cornea surgeon, and Nahum Ferera, an experienced business executive. The company operates within the Van Leer TechnologyIncubator.
- Laclarée — Laclarée develops a pair of adaptive eyeglasses for presbyopia. Its patented technology allows the eyeglasses to adapt in real-time to the scene viewed by the wearer. This major innovation will help milllions of people 45+ years, who are not satisfied with current solutions (progressive lenses, multiple pairs, etc...).
- BELKIN Vision — Imagine an efficient, non-contact glaucoma laser treatment able to alleviate IOP painlessly. Accessible Glaucoma Care at the touch of a button.
Magma is Israel's leading venture capital firm specializing in early-stage investments in communication, semiconductors, internet and media. They seek bright ideas, infuse them with experience and foresight, and facilitate their rise as industry leaders that redefine the global communications sector. They use their experience and sectorspecialization in cooperating with entrepreneurs, industry experts, and other investors to define the future of the communication, semiconductors, internet and media arenas. Their goal is to foster and enable the flow of innovation from an idea's early stages and through a company's emergence as a leader within its dynamic market. They understand the local market and help to influence the global one.
Show more...Investment focus
- Industry: Software, Mobile, Enterprise Software
- Stage:Series A, Series B, Seed
- Geography: Israel, United States, Mexico
Investor stats
- Total investments: 118
- Round size: Seed $800k–$6M; Series A $1.9M–$12M; Series B $6M–$25M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $24M in 2017
Portfolio highlights
- Aidoc — Aidoc is an Israel-based startup providing artificial intelligence tools for radiologists. Their products help detect and pinpoint critical anomalies for radiologists through deep learning and AI algorithms that analyze medical images and patient data. Aidoc eases up the work list and frees up time and attention to what matters. The startupdeidentifies these and sends them onto Aidoc’s cloud, where algorithms identify and highlight abnormalities before returning the images to radiology workstations for reidentification.Aidoc's s solutions aid radiologists in reducing turnaround time and increasing quality and efficiency by flagging acute anomalies in real-time. It also offers tests for intracranial hemorrhages and spinal fractures, plus several chest exams for pulmonary embolisms, pneumothorax, rib fractures, and lung nodules.Aidoc was founded by Guy Reiner, Elad Walach, and Michael Braginsky in 2016 and is headquartered in Tel Aviv, Israel.
- PayKey — The PayKey social banking and mobile P2P payment solution: A patent-pending mobile payment keyboard that seamlessly integrates with your banking application and lets users complete a transaction without leaving their social application.
- Magisto — Magisto online video editor is a fast & powerful video maker. Turn your photos and video clips into video stories with Magisto movie editor. Start free!
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!OTV focuses on round A+ startups that aim to make a significant impact on people's lives. Our focus is on entrepreneurs with innovative ideas who are advancing the global state of well-being. Come join the digital health revolution, and be a part of transforming the healthcare industry.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series B, Seed
- Geography: United States, Israel, Ghana
Investor stats
- Total investments: 21
- Round size: Seed $5M–$8M; Series A $6M–$12M; Series B $16M–$50M
- Lead/follow: 57% lead, 43% follow
- Last fund: May invest from a new fund soon — raised $170M in 2020
Portfolio highlights
- Scopio — Buy & sell images on the largest Solana Photography NFT Marketplace. Find high-quality stock images & hire artists from around the world.
- Scopio Labs — Scopio Labs is a provider of Full Field Morphology dedicated to unlocking the potential of imaging and AI in hematology. Uncovering actionable insights from vast amounts of data readily available in the average blood sample and bone marrow aspirate, Scopio's solutions will aim to showcase thousands of cells at scale in high resolution, toenable new hematology diagnostic methods.
- Stake — Renters earn Cash back for rent. Building operators outperform the market. That's the Stake win-win. Find out how we're building the financial tools for the next generation of rentals.
Iron Nation support Israeli startups financially during a time of terror, helping them survive, their teams keep their jobs, and their company's growth trajectory.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Series A, Series B
- Geography: Israel, United States, Germany
Investor stats
- Total investments: 22
- Round size: Seed $850k–$20M; Series A $3.9M–$6.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- IBI-Ag — IBI-Ag is a biotechnology company developing a new class of bioinsecticides. IBI-Ag is focused on the discovery and development of new types of biological solutions that utilize environmentally friendly technology to control insects. IBI-Ag utilizes breakthrough technology to produce efficient, selective, and safe bio-insect control solutions.IBI-Ag technology is highly cost-effective due to its fermentation suitability enabling farmers to produce agricultural produce at a low cost.
- Ballerine — Ballerine helps financial services compose verification processes for any vertical and geography using modular building blocks, components, and 3rd party integrations.
- Line 5 — Line 5 is a new defense tech startup operating in sleath mode.
Triventures is a global, early stage fund that invests in exceptional entrepreneurs. We partner with disruptive ventures with innovative breakthroughs in healthcare and beyond. Our vision is to create a better, healthier future through data driven solutions and cross industry convergence.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series A, Series B
- Geography: United States, Israel, Ireland
Investor stats
- Total investments: 60
- Round size: Series A $6M–$24M; Series B $6M–$28M
- Lead/follow: 30% lead, 70% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Grin — Grin is a comprehensive digital orthodontic platform providing teeth straightening for all types of patients with a real local orthodontist. The platform also connects patients with a real orthodontist from the convenience of their smart device. They deliver responsible care from orthodontic specialists in an easily accessible and cost-effectiveway, Grin provides patients quality care that results in an exceptional smile together with all of the modernized convenience that they expect.Grin technology, aligned with a network of local trusted orthodontists, ensures that every patient gets the right care. The platform Grin App and Grin Scope is a patent-pending technology that offers remote monitoring for a variety of orthodontic needs. The Grin experience includes high-quality self-scans with the latest teeth straightening solutions. Practitioners and patients can now use these telemedicine tools to achieve a new, more convenient treatment journey.It was founded by Dr. Adam Schulhof, Pamela Oren-Artzi, and Alon Lipnik in 2019 and is based in New York and Austin.
- Cala Health — Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health's wearable therapy is an essential tremor, adisease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.
- TailorMed — Moving Mountains for Patients
Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, 3D Technology
- Stage:Series C, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 14
- Round size: Series C $13M–$22M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Check-Cap — Check-Cap Ltd. is merging with MBody AI to create a leading publicly traded embodied AI company powering autonomous workforces.
- Ocon Healthcare — OCON Healthcare innovates, develops, manufactures, and commercializes cutting-edge women’s health products based on our patented IUB™ (Intra Uterine Ball) proprietary platform. The IUB™, made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.In addition to our flagshipproduct, the IUB™ Ballerine®, OCON healthcare is developing an innovative pipeline of products utilizing the IUB™ frame for indications such as abnormal uterine bleeding (AUB), heavy menstrual bleeding (HMS), myomas/fibroids, and infertility.
- Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
Merz Therapeutics is dedicated to improving the lives of patients around the world with its relentless research, development, and culture of innovation. Merz Therapeutics strives to serve unmet patient needs and realize better outcomes.
Show more...Investment focus
- Industry: Health Care, Therapeutics, Medical Device
- Stage:Corporate Round, Venture - Series Unknown
- Geography: Israel
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Vensica Medical — Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).Using Vensica’s device, the drug will be instilled in a quick, pain-free proceduresubsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates.
VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 28
- Lead/follow: no public data
Portfolio highlights
- Easy Rain — We are Easyrain. Continuous innovation runs in our blood.With our expertise, we develop, simulate, and test solutions, launching our ideas into production. We exploit the basic laws of physics to engineer a tangible solution!
- Sibylla Biotech — Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.
- Alia Therapeutics — Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.
Turkey Development Fund aims to develop the enterprise ecosystem by investing in new generation startups.
Show more...Investment focus
- Industry: Information Technology, Software, SaaS
- Stage:Series A, Seed, Series B
- Geography: Turkey, United Kingdom
Investor stats
- Total investments: 12
- Lead/follow: no public data
Portfolio highlights
- Rnv.ai — RNV Analytics provides AI and ML driven solutions for inventory allocation problem of retail companies. With algorithmics recommendation, their customers decide which product should be located in which sales points both online and offline.
- Delivers.AI — Delivery droid operator
- Eatron Technologies — Intelligent Software Platform for Battery Management System & Intelligent Motion Control - Eatron Technologies
Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Series B, Series C, Series D
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 53
- Lead/follow: no public data
Portfolio highlights
- Anumana — Anumana is a new AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention
- Nectero Medical — Nectero Medical develops a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms. The company was founded in 2017 and is headquartered in Dover, Delaware, United States.
- 4C Medical Technologies — 4C Medical Technologies is a medical device company that develops minimally invasive therapies for structural heart disease. It preserves the native mitral valve and left ventricle, eliminating known issues associated with transcatheter mitral valve replacement technologies that rely on placement and fixation in the native mitral annulus and leftventricle.It was founded in 2015 and headquartered in Maple Grove, Minnesota.
The Chartered Group is an investment platform.
Show more...Investment focus
- Industry: Biopharma, Agriculture, Health Care
- Stage:Series A, Private Equity
- Geography: Israel
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Zsquare — Zsquare has developed the only scalable endoscopic platform capable of transmitting high resolution images in flexible, single-use endoscopes, through polymeric fibers of any shape or size. Zsquare’s imaging technology outperforms existing technologies by delivering higher quality visualizations through smaller diameters than those found inreusable endoscopy systems.Zsquare’s polymeric fiber enables the housing of inexpensive optics with no electronics in a single-use shell, and expensive components in a detachable, reusable imaging core. This platform feature allows the use of a single core with various interchangeable shells which offer differing capabilities for different indications, facilitating any type of endoscopy procedure at a lower costs per-use.
- Pepticom Ltd. — Pepticom is a privately held AI company with headquarters in Israel committed to offering AI peptide drug discovery solutions for a better and healthier world. It is the leader in the emerging peptide drugs software solutions, AI and prediction tools that allow research centers, pharma and agriculture companies to accelerate innovative moleculesdiscovery while reducing time, costs and risks. Pepticom operates in various markets; past successful discoveries include peptide molecules related to metabolic diseases and Immuno-modulators.
Kli Capital is a firm focused on investing in fearless entrepreneurs who are building foundational enterprise technologies and ubiquitous consumer brands. We partner with exceptional founders with unique insights, from inception through all phases of growth.
Show more...Investment focus
- Industry: Health Care, Software, Wellness
- Stage:Seed, Series A
- Geography: United States, Israel, Mexico
Investor stats
- Total investments: 87
- Lead/follow: no public data
Portfolio highlights
- LexCheck — Transform your contract negotiation process with AI. Review, redline and approve contracts quickly and economically with the power of automation.
- VersusGame — VersusGame offers creators and brands the opportunity to cultivate a community with an interactive content solution that rewards knowledge
- Cooper — Your parenting lifeline.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Medtronic develops healthcare technology to treat chronic diseases. Its medical technology is providing lifelong solutions for people with chronic pain. The company is committed to improving lives through its medical technologies, services, and solutions. Medtronic has four main business units: the Minimally Invasive Therapies Group, the DiabetesGroup, the Restorative Therapies Group, and the Cardiac and Vascular Group. Medtronic develops and manufactures devices and therapies to treat more than 30 chronic diseases that include heart failure, Parkinson disease, urinary incontinence, Down syndrome, obesity, chronic pain, spinal disorders, and diabetes.Medtronic was founded in 1949 and is headquartered in Minneapolis, Minnesota, United States
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series C, Series B
- Geography: United States, Israel, China
Investor stats
- Total investments: 82
- Lead/follow: no public data
Portfolio highlights
- FIRE1 — FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
- CathWorks — CathWorks is a medical technology company focused on applying its advanced computational science platform to optimize PCI therapy decisions and elevate coronary angiography from visual assessment to an objective FFRangio based decision-making tool for physicians. FFR-guided PCI decision-making is proven to provide significant clinical benefits forpatients with coronary artery disease and economic benefits for patients and payers. The company’s focus is specifically on bringing the CathWorks FFRangio System to market to provide quick, precise, and objective intraprocedural FFRangio guidance that is practical for every case.
- Avation Medical — 42 million men and women have symptoms of OAB and incontinence. Vivally can help.
IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Seed, Angel, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 104
- Round size: Seed $329k–$5.9M; Angel $219k–$1.2M; Series A $2.7M–$14M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Cato AI — Cato AI is a Milan-based B2B SaaS startup that uses AI to automate public tender management.
- AUDIOGEN — Generate your sounds with AI. Create an infinite world of sounds - sound effects, samples, and music, instantly. Get Started Free.
- Alomana —
Smith & Nephew PLC designs, manufactures and markets orthopedic devices, sports medicine and ENT technologies, and wound-care solutions. Slightly more than 40% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is a sports medicine and ENT. The remaining 27% of revenue is from the advanced wound therapysegment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Show more...Investment focus
- Industry: Medical Device, Medical, Health Care
- Stage:Series B, Series C
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 5
- Round size: Series B $2.7M–$30M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- OrthoSpace — OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures.The company’s first product has the CE mark and iscurrently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion.
- Trice Medical — Perform a full diagnostic arthroscopy on an HD tablet thanks to the mi-eye 2. Get mi-eye 2 for your doctor's office today.
- Miach Orthopaedics — Miach Orthopaedics is a medical device company that develops bio-engineered surgical implants to facilitate new tissue growth. The company's product is the Bridge-Enhanced ACL Repair technology as a viable alternative to conventional ACL reconstruction for patients who have withstand an anterior cruciate ligament injury.Miach Orthopaedicswas founded on 2016 and is headquartered in Westborough, Massachusetts.
At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 259
- Round size: Seed $300k–$5.3M; Series A $2.4M–$25M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $50M in 2023
Portfolio highlights
- 1touch.io — By continuously analyzing traffic and repository stores connected to your network, our network-based solution can detect all elements on the network that are storing, processing, and sharing personal data, both internally and externally. Whether structured or unstructured data, data in motion or at rest, and even data that is unknown to you,1touch.io can track it for you.
- Mobile Sense — The traditional diagnostic market is being transformed by advances in high performance wearables. This seismic shift led by consumer products which are uncovering new patients who previously went undetected, but still require a detailed diagnosis. Mobile Sense™ is building foundational technology that enables this transformation throughoff-the-chest wearables for long term management of cardiac arrhythmias. Developed over 7 years with $4.2M in grant funding and $1.3M in seed funding, Mobile Sense™ has a platform for differentiated wearables. Our embedded algorithms coupled with non-adhesive, wireless & waterproof sensors provides high fidelity continuous ECG and PPG recordings. The automatic monitoring provides 24/7, 365 days/yr continuous detection and classification of dangerous heart arrhythmias.
- LegiTime Technologies — Miami Embracing New Technology and Safety
Explore Arkin Capital: A leading multi-asset manager driving strategic investments across health, technology, equity, real estate and more
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Seed
- Geography: Israel, United States, Switzerland
Investor stats
- Total investments: 31
- Round size: Seed $2M–$6M; Series A $15M–$29M; Series B $23M–$95M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $270M in 2021
Portfolio highlights
- Lendbuzz — Lendbuzz is an AI-based auto finance platform that helps consumers with thin or no credit history obtain financing when purchasing a car. Powered by machine learning and proprietary algorithms, Lendbuzz is able to better assess the creditworthiness of consumers with limited credit history, who are underserved by the traditional banks. By partneringwith auto dealerships, Lendbuzz is able to offer consumers attractive financing solutions and dealerships are able to close additional business opportunities and serve a more diversified client base. Lendbuzz is headquartered in Boston, Massachusetts and was founded in 2015.
- Eleos Health — Eleos Health provides AI-powered, highly compliant documentation automation to ease the operational burden on behavioral healthcare providers.
- Nocion Therapeutics — Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. The company is developing "nocions" which are a new kind of therapy that selectively affects actively firing nociceptors, enabling patients to provide targeted, robust and sustained relief for the treatment ofserious conditions including cough, itch, pain and inflammation.
Tarvenn is an Istanbul-based international investment and advisory firm. Tarvenn has an exceptional knowledge and experience in Turkey, Balkans, Central Asia, North Africa and CIS regions. We build the future with our portfolio, international experience, corporate customers and strategic alliances. Our business is to build yours…
Show more...Investment focus
- Industry: Software, E-Commerce, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Turkey, United States
Investor stats
- Total investments: 19
- Round size: Seed $50k–$600k
- Lead/follow: 58% lead, 42% follow
Portfolio highlights
- RADAAR — A stunning social media management platform for brands, agencies, and startups that want to engage followers, publish unique content, and measure performance.
- Pixa Software — Pixa Software is an e-commerce integration and operations management platform to easily manage order processes.
- Madcraft Studios — Enhance your Trials of Osiris performance with our Destiny 2 Trials Carry guides. Learn strategies to secure wins and climb the ranks!
We are an early stage venture capital firm dedicated to partnering with inspiring entrepreneurs to build breakthrough companies
Show more...Investment focus
- Industry: Software, Machine Learning, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 41
- Round size: Seed $1M–$2.5M; Series A $2.1M–$14M; Series B $15M–$30M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $31M in 2013
Portfolio highlights
- ViewNetic — ViewNetic is an AgTech startup developing unique imaging and machine learning technologies for early, pre-propagation detection of pests and diseases in high-value crops.
- Infiniplex — Infiniplex is an Israel-based startup whose mission is to utilize routine blood testing to screen for genetic tumor biomarkers and to offer preemptive, preventive, and follow-up cancer screenings at a more accessible and affordable cost. Our goal is to identify common and rare cancer types through a standard, inexpensive blood test that could becarried out as part of routine checkups, leveraging existing laboratory equipment and know-how. We aim to include tumor genomic testing as part of people's standard blood test checkups. The company was founded in 2021 and is based in Yokne'am Illit, Israel.
- Intuition Robotics — The AI care companion robot for older adults
Keiretsu Forum is a community of private equity investors, business leaders and entrepreneurs with a network of over 50 global chapters and more than 2,500 investor members.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Series A, Seed
- Geography: United States, Spain, Canada
Investor stats
- Total investments: 111
- Round size: Seed $507k–$3M; Series A $600k–$8M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- iQure Pharma — iQure Pharma preclinical and clinical drug development
- Levered Learning — Levered Learning is a classroom-tested and teacher-designed instructional system providing 3rd-5th grade mathematical learning. The company was founded in 2017 by Mitch Slater and is headquartered in Soquel, California, United States.
- Vartega — Vartega is a technology development company specializing in the carbon fiber-reinforced plastic recycling process. We have developed alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass market applications.
Emerge is an early stage, Tel-Aviv based Venture Capital firm, partnering with exceptional tech-innovators and helping them do whatever it takes to win.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 44
- Round size: Seed $2.5M–$11M; Series A $5M–$21M; Series B $16M–$80M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Zyg — ZyG is an Operating System for eCom scale, turning great products into successful brands. ZyG's platform is designed to help product inventors and DTC brands validate, scale, and finance their growth, powered by data-driven AI agents
- Chamelio — Chamelio builds intelligent technology for in-house legal teams. We understand that every in-house legal team operates uniquely - shaped by their industry context, company culture, and strategic priorities. Our platform adapts to these distinct characteristics, delivering hyper-personalized workflows that evolve with your team's specific needs.
- Xpand (formerly 1MRobotics) — Last mile delivery challenge, solved!
Impact investing in Israeli technology. ZORA is an impact investing fund investing in early-stage Israeli companies solving global challenges in health, education, economic inclusion and the environment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Internet
- Stage:Seed, Series A, Convertible Note
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 14
- Round size: Seed $1M–$7M; Series A $4M–$8.1M
- Lead/follow: 7% lead, 93% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Newmoo — Newmoo makes plant-based cheeses and dairy alternatives.
- WeedOut — WeedOut: Exploiting Sterility against Resistant Weeds
- Forsea Foods — Forsea Foods develops cell-cultured seafood through the use of patented organoid technology which allows them to bypass the scaffolding stage of cultivated meat production.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Sanara Ventures is an innovation-investment platform, elevating outstanding healthcare-technology companies, from early-stage to global market maturity. At Sanara, They share a vision of an integrated continuum of care supported by accessible advanced healthcare solutions for people around the world.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Series A
- Geography: Israel
Investor stats
- Total investments: 8
- Round size: Seed $800k–$2.7M; Series A $4M–$6M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Panacea-ml — Panacea-ml revolutionizes clinical trial design with its data-driven, explainable-AI SaaS platform. Our cutting-edge technology addresses the primary causes of clinical development failure by identifying patient profiles that maximize therapeutic efficacy, minimize safety risks, and improve participant retention. Leveraging historical clinicaltrials and millions real-world patient health records, Panacea-ml's AI model enhances patient selection criteria, reduces cohort sizes, and uncovers novel marker-endpoint interrelations, surrogate markers, and causal relationships beyond simple statistical correlations.Our platform is a game-changer for the pharmaceutical industry, facilitating seamless collaboration across drug development, data science, and clinical teams. It accelerates drug development by generating precise sub-population profiles, refining patient selection criteria, and providing informed go/no-go decisions for each phase of development. Panacea-ml is versatile, supporting small sample sizes and various therapeutic domains, including rare diseases and early development stages.At Panacea-ml, we believe in empowering innovation and fostering collaboration to drive impactful outcomes. Our mission is to shorten time to market and enable early access to innovative treatments for patients worldwide.
- CVAid Medical — CVAid Medical develops an innovative AI based stroke detection technological platform.
- TailorMed — Moving Mountains for Patients
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 319
- Round size: Series A $6.6M–$70M; Series B $10M–$109M; Series C $12M–$100M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
- GFBiochemicals — GFBiochemicals is the only company to produce levulinic acid at commercial scale directly from biomass.In 2008, a group of biobased chemical experts saw the significant potential of levulinic acid to replace petroleum-based products across a range of market sectors. GFBiochemicals was founded to develop the production technology needed for thisrevolution in chemicals and biofuels.GFBiochemicals demonstrated these breakthrough technologies in the Caserta plant, in partnership with the University of Pisa and the Polytechnic University of Milan. This commercial-scale plant was retrofitted with new conversion, recovery and purification technology.
- Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
Mithril is a family of long-term venture capital funds agnostic to sector and geography. We invest and partner with teams who use technology to build valuable and lasting businesses, often in industries long overdue for change.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series C, Series B, Series D
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 68
- Round size: Series B $10M–$150M; Series C $15M–$142M; Series D $15M–$300M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — raised $850M in 2017
Portfolio highlights
- Neocis — Yomi, a dental robot, is the next generation in implant surgery that can give patients a better experience, expand your offerings and boost your efficiency
- GreyOrange — Learn about GreyOrange 2026 from GreyOrange, where AI-driven warehouse and retail store solutions reduce costs, increase accuracy and power omnichannel success.
- Helion Energy — Enabling a future with unlimited clean energy
Joyance Partners invests in companies that, through science and tech, cultivate joy to improve how we live, focusing on the health and consumer sectors from Pre-Seed to Series A.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Wellness
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Germany, United Kingdom
Investor stats
- Total investments: 107
- Round size: Seed $750k–$5.2M; Pre-Seed $425k–$2M; Series A $3.6M–$13M
- Lead/follow: 7% lead, 93% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Oga — Fun Dance App.
- KilgourMD — KilgourMD develops hair and scalp care products for reducing shedding and supporting scalp health. They formulate topical serums and treatment solutions. Their products address hair loss prevention and scalp maintenance.
- Lucky Energy — LUCKY F*CK is a better-for-you energy drink company.
HealthpointCapital, LLC is a values-based, research-driven private equity firm that is differentiated by its focus on the musculoskeletal industry. HealthpointCapital has over $800 million of assets under management, including co-investments, resulting in 24 corporate acquisitions for HealthpointCapital's seven platform businesses. The sevenplatform companies, Alphatec Spine, Inc., BioHorizons Implant Systems, Inc., Blue Belt Technologies, Inc., China Rehabilitation Ltd., MicroDental, Inc., Nexa Orthopedics, Inc. and OrthoAccel Technologies, Inc., represent outstanding platforms in some of the key high-growth segments of the orthopedic industry: Robotics, Spine, Dental, Extremities and Emerging Markets.
Show more...Investment focus
- Industry: Medical, Biotechnology, Manufacturing
- Stage:Series B, Series C
- Geography: Israel, United States
Investor stats
- Total investments: 7
- Round size: Series B $5M–$13M; Series C $12M–$15M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- OrthoSpace — OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures.The company’s first product has the CE mark and iscurrently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion.
- OrthoAccel Technologies — Straighten Your Smile Faster With AcceleDent SoftPulse Technology. Simple To Use, Allowing Braces To Feel More Comfortable With Only 20 Minutes Daily Use!
aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science toaccelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 77
- Round size: Series A $5.7M–$83M; Series B $22M–$93M; Series C $30M–$82M
- Lead/follow: 49% lead, 51% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Adcytherix — Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
- Lin Health — Online chronic pain recovery program designed to get you back to the life you want to live. One-on-one coaching. Real pain reduction results.
- Connie Health — At Connie Health, our Medicare advisors help older Americans find the right Medicare plan - all at no cost to you.
Israel Biotech Fund – Building the future of Israeli BiotechIsrael Biotech Fund seeks high value returns by identifying and maximizing the success of therapeutic assets of Israel-based biotech companies.Based in Rehovot, Israel’s main Biotech hub, we invest exclusively in Biotech companies developing drugs at or near clinical stages.Ourpartners include two top-tier international pharmaceuticals companies, institutional investors, family offices and high net worth individuals.Our key asset is a unique team of 25 Venture Advisors, comprised of renowned industry leaders and professionals who, together with the fund’s managing partners, provide our portfolio companies with hands-on guidance and support.We don’t just invest in promising companies – we have the ability, experience and network required to identify the best opportunities and partner with our portfolio companies to help them go the distance.We provide our portfolio companies with the necessary resources for long-term sustainable growth. This approach enhances their value and the investor’s long-term capital appreciation, while strengthening Israel’s Biotech industry which increases investment opportunities.The biotechnology industry in Israel is growing with enormous potential and we are determined to realize its full potential and real value.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series B, Series C, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 13
- Round size: Series A $9M–$17M; Series B $17M–$30M; Series C $19M–$45M
- Lead/follow: 69% lead, 31% follow
- Last fund: May invest from a new fund soon — raised $65M in 2019
Portfolio highlights
- Ukko — Our mission is to improve the lives of the millions that suffer from food allergies and gluten-related disorders
- MediWound — MediWound is a biotechnology niche-specialty company. Established in 2001, MediWound is focused on developing, manufacturing, and globally commercializing innovative products that address unmet needs in the fields of severe burns and chronic wound management.MediWound’s goal is to provide healthcare professionals and patients with its innovativeburn wound eschar removal agent, NexoBrid. NexoBrid successfully completed clinical development in hospitalized burn wounds and is approved and ready to launch in Europe.
- Vensica Medical — Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).Using Vensica’s device, the drug will be instilled in a quick, pain-free proceduresubsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates.
TechWald Holding S.P.A. - TWH - Operational Holding Company supporting high growth potential early stage companies committed to develop Healthcare Innovation.We have a key strategy focus on MedTech industry and Medical Technologies - medical devices, equipment, digital devices and services -which can provide benefit and value for Patients, Doctors and Healthcare Systems,and reward Shareholders with a sound and ethical profit
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series B, Series C
- Geography: Israel, Switzerland, United States
Investor stats
- Total investments: 9
- Round size: Series A $3.6M–$7.1M; Series B $8.5M–$20M; Series C $9.3M–$60M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- NitiNotes — Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight.
- SentiAR — SentiAR is digital health, software device company adding a new dimension to clinical practice in interventional procedures. Spun out of Washington University, we are developing the first 3D visualization platform using real-time holography of the patient's anatomy and catheter location, "floating" over the patients, with a goal toprovide the clinician and patient a faster, safer delivery of care.SentiAR’s mission is to transform the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient.The visualization is fully controllable “hands-free” by the clinician, providing an ergonomic breakthrough for the treatment and analysis of cardiac arrhythmias within an interventional catheter lab environment. SentiAR is developing the platform for eventual FDA submission.
- Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.
Chartered Opus offers professional market participants (clients such as asset managers) the opportunity to realise “securitised” concepts/products for their own investment or for their customers.
Show more...Investment focus
- Industry: Wellness, Biotechnology, Manufacturing
- Stage:Series A
- Geography: Israel
Investor stats
- Total investments: 3
- Round size: Series A $3M–$3.5M
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- SolCold — We make the sun cool again - Solcold the new environment solutions
- Trobix Bio — Trobix Bio is a company that develops and commercializes antibacterial products. It has developed platform technologies called ActiSense and GOTrap for developing high-quality products that remove the threat of antimicrobial resistance.
Healthcare innovation wherever it originates.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 73
- Round size: Series A $5.9M–$63M; Series B $18M–$55M; Series C $300k–$100M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Moon Surgical — Create the OR of the future, one that is sustainable, efficient, and digitalized.
- Manus Neurodynamica — Manus Neurodynamica is a triage device to support early diagnostics in Parkinson's disease.
- Glyphic Biotechnologies — We sequence proteins. We have exciting updates coming soon... Contact us or sign up for updates below to be the first to know. Let's Chat. Partner. Collaborate. Team Up. Discuss. Talk. Co-Develop. Let's build something great and change the future of proteomics together. Send us a message! Subscribe to our updates!
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device VC Funds in Middle East investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 VC funds investing in Middle East Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!